Product Details

Verfluc Capsules meet British Pharmacopoeia (BP) standards for the treatment of fungal infections. Specifically, each capsule delivers Fluconazole BP at 150mg. As a result, it offers effective, single-dose or short-course antifungal therapy for a range of common fungal infections.

The capsules contain:

• Fluconazole BP (150mg) – A triazole antifungal that inhibits fungal cytochrome P450-dependent enzymes essential for ergosterol synthesis. Consequently, it disrupts fungal cell membrane integrity, exerting fungistatic and, at higher concentrations, fungicidal activity against susceptible yeasts and fungi.

Physicians prescribe Verfluc for the treatment of vaginal candidiasis, oral and oesophageal candidiasis, and other systemic fungal infections. In addition, its single-dose regimen for uncomplicated infections supports simple, effective treatment with high patient compliance. Because of this profile, Verfluc suits general practice, gynaecology, and dermatology settings managing fungal infections.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the oral capsule format supports simple, convenient dosing
• Furthermore, each capsule delivers precise, validated dosage accuracy at 150mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, blister packaging protects capsule integrity against light
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies